Pharma Focus Asia

Nagasaki University Collaborates with NEC OncoImmunity

Monday, August 21, 2023

Nagasaki University and NEC OncoImmunity have announced collaboration focused on leveraging NOI's cutting-edge AI platform to develop universal vaccines capable of addressing the challenges posed by highly pathogenic and tropical infectious diseases.

The collaboration between NOI and Nagasaki University is driven by the shared objective of harnessing the capabilities of advanced AI technology to refine vaccine designs. The ultimate goal is to create vaccines that offer broad and universal protection against specific pathogen families that are prevalent in tropical regions.

Under the scope of the collaboration, NOI's AI technology will be deployed to create vaccines that target both T cell and B cell immune responses. By combining Nagasaki University's tropical medicine expertise with NEC's advanced AI technology, substantial progress in global vaccine development can be achieved for improved public health.

The collaboration aims to showcase interdisciplinary research at the intersection of computer technology and Tropical Medicine. This partnership holds the potential to substantially advance vaccine development efforts.

magazine-slider-imageMFA + MMA 2024CPHI Chine || PMEC China 2024Asia Healthcare Week 2024Advance DoE WorkshopNitrosamine Advance Workshop 2024CPHI Korea 2024CHEMICAL INDONESIA 2024INALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024Rehab Expo 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024LogiPharma Asia 2024